1 Offer
2 Data
3 Health
4 Summary
5 Payment

Specify pregnancy type

Choose a service option.

You can secure up to three types of biological material with PBKM. Each one increases the scope of your family’s protection.

Learn more about the options

Your fees summary

Payable before childbirth -

within 2 days from signing the contract -

Payable after childbirth -

within up to 8 weeks after childbirth -

within up to 8 weeks after childbirth -

Summary amount to pay: -

Subscription fees -

According to the selected subscription type -

Yearly payment

According to the selected subscription type -

Monthly payment

You have selected monthly fee option

Payment form I have a promotional code
Hide

If you have any questions, call us: +48 797 450 000

The order cannot be continued.

You have answered “yes” to one of the questions which constitute an absolute contraindication for supplying this service. Please stop your order and contact the Customer Service Department.

The answers provided suggest contraindications for acquiring umbilical cord blood and placental blood. You may continue with the ordering process nonetheless or contact the Customer Service Department.

Learn more at: https://www.pbkm.pl/en/faq

The answer provided indicates that umbilical cord collection is not possible. Go back to Step 1 – Configure offer and select a service option which does not include umbilical cord collection or contact the Customer Service Department.

Learn more at: https://www.pbkm.pl/en/faq

This response disqualifies you from obtaining biological material for public purposes. The Umbilical Cord Donation option will be deactivated, and you will be redirected to the OFFER Step with additional options to provide the kit unlocked.

Jeżeli uzyskamy z krwi Matki wynik w Laboratorium PBKM: IgM [ujemne] oraz IgG [wątpliwe lub dodatnie] to istnieje możliwość przechowywania sznura pępowinowego na cele publiczne. Jednak ostateczną decyzję dotyczącą wykorzystania komórek podejmuje indywidualnie u każdego pacjenta lekarz prowadzący procedurę medyczną. Jeżeli uzyskamy z krwi Matki wynik w Laboratorium PBKM: IgM [wątpliwe lub dodatnie] + IgG [wątpliwe lub dodatnie lub ujemne] to nie będzie możliwości przechowywania sznura pępowinowego na cele publiczne (w/w materiał biologiczny zostanie zdyskwalifikowany).

According to current medical knowledge, the information provided may constitute a contradiction for using umbilical cord for the manufacture of a medicinal product.

Learn more at: https://www.pbkm.pl/en/faq

According to current medical knowledge, unknown cause of miscarriage or more than one miscarriage may constitute a contradiction for using umbilical cord for the manufacture of a medicinal product.

Umbilical cord/MSC may be stored to be used only for the mother, the father or the child (potentially siblings, grandparents) whose results confirm previous Toxoplasma gondii infection. However, the final decision concerning the use of cells is made individually for each patient by the physician performing the medical procedure. NOTE: The administration of the cells into the cerebrospinal fluid is prohibited.

If we obtain the following results: IgM [negative] and IgG [equivocal or positive] from the mother’s blood at the PBKM laboratory, then the umbilical cord/MSC can be stored to be used only for the mother or child (siblings, grandparents) whose results confirm previous Toxoplasma gondii infection. If we obtain the following results: IgM [equivocal or positive] + IgG [equivocal or positive or negative] from the mother’s blood at the PBKM laboratory, the storage of umbilical cord fragments/MSC will not be possible (the above-mentioned biological material will be disqualified).

Additional testing for viral DNA will be performed during the manufacture of a medicinal product from umbilical cord cells. If the results of this test are positive, the umbilical cord/MSC may only be used for the mother, father or child (potentially siblings, grandparents) whose results will confirm a previous cytomegalovirus infection. In the case of a negative DNA test result, there are no restrictions of use.

If we obtain the following results: IgM [reactive/equivocal] and/or IgG [reactive/equivocal] from the mother’s blood at the PBKM laboratory, then additional testing for viral DNA will be performed during the manufacture of a medicinal product with cord cells. If the results of this test are positive, the umbilical cord/MSC may only be used for the mother, father or child (potentially siblings, grandparents) whose results will confirm a previous cytomegalovirus infection. In the case of a negative CMV DNA test result, there are no restrictions of use.

Collection and storage of umbilical cord blood and placental blood are possible. The transplantation center physician will decide whether it may be used for transplantation.

Positive or equivocal results for IgM antibodies may constitute a contraindication for the future use of acquired umbilical cord blood/placental blood. The decision is always made by the transplantation centre physician.

At the present state of knowledge, this disease is an indication for the use of umbilical cord cells. If you want to bank the umbilical cord tissue in order to quickly use it for family therapy, it will not be possible in the near future. Hashimoto's disease is not an indication for future use of umbilical cord or placental blood.

Anti-cytomegaly antibodies level test results are no contraindication for umbilical cord blood/placental blood collection.

Additional genetic testing may be required prior to the manufacture of a medicinal product from Umbilical cord cells or Placental Tissue in order to rule out the possibility of transferring a genetic defect to the patient. This may be associated with a long waiting time for the medicinal product or disqualification of the material at a later date.

I would like to cancel umbilical cord collection

Umbilical cord may be collected, but the medicinal product may only be manufactured for and used by a person who was also vaccinated against smallpox.

I would like to cancel umbilical cord collection

Additional genetic testing may be required prior to the manufacture of a medicinal product from Umbilical cord cells or Placental Tissue in order to rule out the possibility of transferring a genetic defect to the patient. This may be associated with a long waiting time for the medicinal product or disqualification of the material at a later date.

I would like to cancel umbilical cord collection

Abnormalities identified in an invasive prenatal examination do not necessarily mean that a genetic defect will certainly be present after birth, however, confirmation of a genetic defect after birth will constitute an absolute contraindication for the use of umbilical cord in treatment.

I would like to cancel umbilical cord collection

No contraindications for cord acquisition

No contraindications for blood acquisition

Absolute contraindication for cord collection

Blood may be acquired but the presence of bacteria in the child must be ruled out after birth

I would like to cancel

Blood acquisition is not possible

Cord / placental blood can be obtained, but there is a risk that the material may be disqualified from further use in the future if the diagnosis is changed to a malignant tumor in the mother within 5 years of collection, due to the risk of transmitting neoplastic disease.

In accordance with FDA guidelines, a doctor from a transplant center may use such a transplant unit in cases of medical emergency (e.g. severe illness or imminent risk of death when no other suitable units are available) or for allogeneic use in first or second degree relatives, or for autologous use.

If it is necessary to use the banked material, providing the gamete donor’s medical history is required. Lack of medical information concerning the genetic mother (ovum donor) may prevent using the child’s umbilical cord blood and/or placental blood. The decision about the final use of the blood unit will be made by the transplantation center physician.

I would like to cancel biological material collection

If it is necessary to use the banked material, providing the sperm donor’s medical history is required. Lack of medical information concerning the genetic father (sperm donor) may prevent using the child’s umbilical cord blood and/or placental blood. The decision about the final use of the blood unit will be made by the transplantation center physician.

I would like to cancel biological material collection

If it is necessary to use the banked material, providing the ovum donor’s and sperm donor’s medical history is required. Lack of information concerning the medical history of the genetic mother (ovum donor) and genetic father (sperm donor) may prevent using the child’s umbilical cord blood and/or placental blood.

I would like to cancel biological material collection

Due to the possibility of Mother prion infection, the decision on the final use of the Biological Material is made by a doctor from the transplantation centre.

If the disease is cured, then the mother may be eligible for banking 12 months after completion of treatment. If treatment is still ongoing or 12 months have not passed yet since cure, cord blood should not be banked.

I would like to cancel

If the disease is cured then the Mother may be eligible for donation 12 months after completion of treatment if there is no organ or neurological failure caused by the disease. If treatment is still ongoing or 12 months have not passed yet, or the Mother has the above disorders, Biological Material should not be banked.

I would like to cancel

The presence of antibodies is not the same as HIV infection (a large percentage of screening tests are false positive). Our laboratory will perform additional tests - including PCR to rule out or confirm infection.

I would like to cancel

There is a 5 year disqualification period for intravenous use of drugs not prescribed by a doctor.
If 5 years have not yet passed, cord blood should not be banked.

I would like to cancel

For haemorrhagic fevers there is a ban on donations until one year after recovery.
If one year since recovery from the illness did not pass, cord blood should not be banked.

I would like to cancel

Were they harmless to the child water-soluble vitamins in recommended (small) doses or vitamin D and E in recommended doses; or vitamin C in recommended doses or herbal syrups e.g. cough suppressants or urinary tract decontaminants with cranberry fruit extract or antipyretic preparations based on medicinal plant extracts?

Please indicate trimester

Please indicate trimester

Were they thyroid medications e.g. Euthyrox, Letrox due to hypothyroidism; dietary supplements with sedative effect containing melissa, hawthorn or valerian or other herbal medicines or dietary supplements containing magnesium and/or calcium; folic acid preparations; stomach acid neutralizers i.e. preparations containing calcium and magnesium carbonates; ointments and suppositories used to treat hemorrhoids containing yeast extract and shark liver oil?

I undertake to inform PBKM if I am infected with SARS-CoV-2 virus (coronavirus) during pregnancy or by the 21st day after childbirth, or if the child is infected with SARS-CoV-2 virus (coronavirus) during the 21 days after childbirth .
I undertake to provide PBKM with the necessary medical documentation, i.e. test results confirming my (mother) and / or child's infection.
- by e-mail to the address biuro@pbkm.pl within 30 days from the date of delivery at the latest.
If the results of the Mother's and / or Child's tests are not provided, the biological material will be stored in accordance with the rules set out in the Agreement.
Infection with the SARS-CoV-2 virus in a child is a contraindication to the future use of the obtained biological material (umbilical cord and / or placenta cells).
Infection with the SARS-CoV-2 virus in the mother may constitute a contraindication to the use of the acquired biological material (umbilical cord and / or placenta cells) in the future.

Already our customer?
Claim your discount!